Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [48 citations: 48 articles]

Articles published in Lung Cancer International have been cited 48 times. The following is a list of the 48 articles that have cited the articles published in Lung Cancer International.

  • Jennifer L. Hunt, Alfio Ferlito, Henrik Hellquist, Alessandra Rinaldo, Alena Skálová, Pieter J. Slootweg, Stefan M. Willems, and Antonio Cardesa, “Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx,” Advances In Anatomic Pathology, vol. 24, no. 3, pp. 161–168, 2017. View at Publisher · View at Google Scholar
  • Seung Hee Choi, and Manfred Stommel, “Impact of Age at Smoking Initiation on Smoking-Related Morbidity and All-Cause Mortality,” American Journal of Preventive Medicine, 2017. View at Publisher · View at Google Scholar
  • Kareem Ahmad, Luke Gabe, Elaine Cristan, and Phillip Factor, “Interventional Pulmonology: Determining an Ideal Technique, Phenotype-driven Management, and Finding Safer Alternatives,” American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 5, pp. 649–651, 2017. View at Publisher · View at Google Scholar
  • David Spigel, Alexander Luft, Henrik Depenbrock, Rodryg Ramlau, Mazen Khalil, Joo-Hang Kim, Carlos Mayo, Grace Yi Chao, Coleman Obasaju, and Ronald Natale, “An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer,” Clinical Lung Cancer, 2017. View at Publisher · View at Google Scholar
  • David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh, and Nick Pavlakis, “Prognostic and predictive biomarkers in neuroendocrine tumours,” Critical Reviews in Oncology/Hematology, vol. 113, pp. 268–282, 2017. View at Publisher · View at Google Scholar
  • Zhi-Jie Xiao, Jing Liu, Si-Qi Wang, Yun Zhu, Xu-Yuan Gao, Vicky Pui-Chi Tin, Jing Qin, Jun-Wen Wang, and Maria Pik Wong, “NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma,” eLife, vol. 6, 2017. View at Publisher · View at Google Scholar
  • Nerea Fernández de Larrea-Baz, Angelika Michel, Beatriz Romero, Beatriz Pérez-Gómez, Victor Moreno, Vicente Martín, Trinidad Dierssen-Sotos, José J. Jiménez-Moleón, Jesús Castilla, Adonina Tardón, Irune Ruiz, Rosana Peiró, Antonio Tejada, María D. Chirlaque, Julia A. Butt, Rocío Olmedo-Requena, Inés Gómez-Acebo, Pedro Linares, Elena Boldo, Antoni Castells, Michael Pawlita, Gemma Castaño-Vinyals, Manolis Kogevinas, Silvia de Sanjosé, Marina Pollán, Rosa del Campo, Tim Waterboer, and Nuria Aragonés, “Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain,” Frontiers in Microbiology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Michael Schivo, Timothy E Albertson, Angela Haczku, Nicholas J Kenyon, Amir A Zeki, Brooks T Kuhn, Samuel Louie, and Mark V Avdalovic, “Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease,” Journal of Investigative Medicine, vol. 65, no. 6, pp. 953–963, 2017. View at Publisher · View at Google Scholar
  • Farshad Foroudi, Jennifer G Smith, Faye Putt, and Morikatsu Wada, “High-dose palliative radiotherapy for malignant pleural mesothelioma,” Journal of Medical Imaging and Radiation Oncology, 2017. View at Publisher · View at Google Scholar
  • Naoya Yoshida, Kazuto Harada, Yoshifumi Baba, Keisuke Kosumi, Masaaki Iwatsuki, Koichi Kinoshita, Kenichi Nakamura, Yasuo Sakamoto, Yuji Miyamoto, Ryuichi Karashima, Kosuke Mima, Hiroshi Sawayama, Mayuko Ohuchi, Akira Chikamoto, Yu Imamura, Masayuki Watanabe, and Hideo Baba, “Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer,” Langenbeck's Archives of Surgery, 2017. View at Publisher · View at Google Scholar
  • Filip Kaniski, Lindsey Enewold, Anish Thomas, Shakuntala Malik, Jennifer L. Stevens, and Linda C. Harlan, “Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010,” Lung Cancer, vol. 103, pp. 66–74, 2017. View at Publisher · View at Google Scholar
  • A. V. Chernichenko, I. A. Mescheryakova, A. V. Boiko, V. V. Sokolov, L. V. Telegina, D. V. Sokolov, and V. A. Gerasimov, “Endobronchial radiotherapy in the treatment of patients with tracheal and lung cancer,” Onkologiya. Zhurnal imeni P.A.Gertsena, vol. 6, no. 4, pp. 9, 2017. View at Publisher · View at Google Scholar
  • Jing Jin, Kejia Hu, Yongzhao Zhou, and Weimin Li, “Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis,” Plos One, vol. 12, no. 9, pp. e0184412, 2017. View at Publisher · View at Google Scholar
  • Chang Heon Choi, Jong Min Park, So-Yeon Park, SungHee Kang, Jin Dong Cho, and Jung-in Kim, “Evaluation of Dosimetric Effect and Treatment Time by Plan Parameters for Endobronchial Brachytherapy,” Progress in Medical Physics, vol. 28, no. 2, pp. 39, 2017. View at Publisher · View at Google Scholar
  • Radoslaw Charkiewicz, Jacek Niklinski, Jürgen Claesen, Anetta Sulewska, Miroslaw Kozlowski, Anna Michalska-Falkowska, Joanna Reszec, Marcin Moniuszko, Wojciech Naumnik, and Wieslawa Niklinska, “Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC,” Translational Oncology, vol. 10, no. 3, pp. 450–458, 2017. View at Publisher · View at Google Scholar
  • Namita Pandey, Shikha Dhiman, Tapasya Srivastava, and Sudip Majumder, “Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment,” Chemico-Biological Interactions, 2016. View at Publisher · View at Google Scholar
  • Kirsty Wai-Chung Lee, and Stephen Lam Chan, “Hepatotoxicity of targeted therapy for cancer,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Emily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, and James Chih-Hsin Yang, “Safety of gefitinib in non-small cell lung cancer treatment,” Expert Opinion on Drug Safety, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Megan Baumgart, and Kishan Pandya, “The use of biomarkers in the treatment of non-small cell lung cancer,” Expert Review of Precision Medicine and Drug Development, vol. 1, no. 1, pp. 25–36, 2016. View at Publisher · View at Google Scholar
  • Rita Mendes, Bárbara Carreira, Pedro V. Baptista, and Alexandra R. Fernandes, “Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology,” Expert Review of Precision Medicine and Drug Development, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Parthasarathy Arumugam, and Joon Myong Song, “Quantitative evaluation of ABC transporter-mediated drug resistance based on the determination of the anticancer activity of camptothecin against breast cancer stem cells using TIRF,” Integr. Biol., 2016. View at Publisher · View at Google Scholar
  • Pietro Bertoglio, Federico Davini, Franca M.A. Melfi, and Alfredo Mussi, “eComment. Marking techniques can increase the use of minimally invasive surgery for small and deep nodules of the lung,” Interactive CardioVascular and Thoracic Surgery, vol. 22, no. 2, pp. 207–207, 2016. View at Publisher · View at Google Scholar
  • Łukasz J. Binkowski, Paweł Rogoziński, Martyna Błaszczyk, Magdalena Semla, Patrick M. Melia, and Robert Stawarz, “Relationship between air pollution and metal levels in cancerous and non-cancerous lung tissues,” Journal of Environmental Science and Health, Part A, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Marco Tomasetti, Monica Amati, Jiri Neuzil, and Lory Santarelli, “Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy,” Lung Cancer, 2016. View at Publisher · View at Google Scholar
  • Alan P. Fields, Syed A. Ali, Verline Justilien, and Nicole R. Murray, “ Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC ,” Small GTPases, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Zhong-Yang Wang, Hong-Yan Li, Zongpei Jiang, Tian-Biao Zhou, and Gregor P.C. Drummen, “ GSTM1 Gene Polymorphism is Implicated in Increased Susceptibility to Prostate Cancer in Caucasians and Asians,” Technology in Cancer Research and Treatment, vol. 15, no. 6, pp. NP69–NP78, 2016. View at Publisher · View at Google Scholar
  • Shigehiro Yagishita, Hidehito Horinouchi, Kuniko S. Sunami, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Minako Sumi, Kouya Shiraishi, Takashi Kohno, Koh Furuta, Koji Tsuta, Tomohide Tamura, and Yuichiro Ohe, “ Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer ,” Cancer Science, 2015. View at Publisher · View at Google Scholar
  • Wing-Hin Lee, Ching-Yee Loo, Daniela Traini, and Paul M Young, “Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages,” Expert Opinion on Drug Delivery, pp. 1–18, 2015. View at Publisher · View at Google Scholar
  • Eric P. Xanthopoulos, Elizabeth Handorf, Charles B. Simone, Surbhi Grover, Annemarie T. Fernandes, Sonam Sharma, Michael N. Corradetti, Tracey L. Evans, Corey J. Langer, Nandita Mitra, Anand Shah, Smith Apisarnthanarax, Lilie L. Lin, and Ramesh Rengan, “Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study,” Practical Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • Papa Anselmo, Rossi Luigi, Verrico Monica, Di Cristofano Claudio, Moretti Valentina, Strudel Martina, Zoratto Federica, Minozzi Marina, and Tomao Silverio, “Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation,” The Clinical Respiratory Journal, 2015. View at Publisher · View at Google Scholar
  • Nick Thatcher, Fred R Hirsch, Alexander V Luft, Aleksandra Szczesna, Tudor E Ciuleanu, Mircea Dediu, Rodryg Ramlau, Rinat K Galiulin, Beatrix Bálint, György Losonczy, Andrzej Kazarnowicz, Keunchil Park, Christian Schumann, Martin Reck, Henrik Depenbrock, Shivani Nanda, Anamarija Kruljac-Letunic, Raffael Kurek, Luis Paz-Ares, and Mark A Socinski, “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial,” The Lancet Oncology, 2015. View at Publisher · View at Google Scholar
  • Mariangela Vanalli, and Francesca Rio, “Development of a core outcome set based on Case Report Form (CRF) to assess laboratory biomarkers and clinical parameters in Onco-Hematology area,” Trials, vol. 16, no. S1, 2015. View at Publisher · View at Google Scholar
  • Kuixing Zhang, “Large-cell neuroendocrine carcinoma (LCNEC) without pulmonary symptoms diagnosed in a cutaneous metastasis: A case report,” American Journal of Case Reports, vol. 15, pp. 97–102, 2014. View at Publisher · View at Google Scholar
  • Anna E. Prizment, Hiroshi Yatsuya, Pamela L. Lutsey, Jay H. Lubin, Mark Woodward, Aaron R. Folsom, and Rachel R. Huxley, “Smoking Behavior and Lung Cancer in a Biracial Cohort,” American Journal of Preventive Medicine, vol. 46, no. 6, pp. 624–632, 2014. View at Publisher · View at Google Scholar
  • Akari Minami, Atsuko Nakanishi, Yasunori Ogura, Yasuko Kitagishi, and Satoru Matsuda, “Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Paweł Krawczyk, Tomasz Kucharczyk, Dariusz M. Kowalski, Tomasz Powrózek, Rodryg Ramlau, Ewa Kalinka-Warzocha, Kinga Winiarczyk, Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk, Katarzyna Kałakucka, Wojciech Dyszkiewicz, Maciej Krzakowski, and Janusz Milanowski, “Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients,” Journal of Cancer Research and Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • Derek Grose, David S. Morrison, Graham Devereux, Richard Jones, Dave Sharma, Colin Selby, Kirsty Docherty, David McIntosh, Marianne Nicolson, Donald C. McMillan, and Robert Milroy, “The impact of comorbidity upon determinants of outcome in patients with lung cancer,” Lung Cancer, 2014. View at Publisher · View at Google Scholar
  • Vijaya Raj Bhatt, Rishi Batra, Peter T. Silberstein, Fausto R. Loberiza, and Apar Kishor Ganti, “Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans’ Affairs Central Cancer Registry (VACCR) cohort analysis,” Medical Oncology, vol. 32, no. 1, 2014. View at Publisher · View at Google Scholar
  • D. Neil Hayes, Guangbin Peng, Eduardo Pennella, Anwar Hossain, Gebra Cuyun Carter, Catherine Muehlenbein, and Coleman Obasaju, “An exploratory subgroup analysis of race and gender in squamous cancer of the head and neck: Inferior outcomes for African American males in the LORHAN database,” Oral Oncology, 2014. View at Publisher · View at Google Scholar
  • Danilo do Rosario Pinheiro, Wallax Augusto Silva Ferreira, Mariceli Baia Leao Barros, Mariana Diniz Araujo, Symara Rodrigues-Antunes, and Barbara do Nascimento Borges, “Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications,” World Journal of Gastroenterology, vol. 20, no. 33, pp. 11574–11585, 2014. View at Publisher · View at Google Scholar
  • Yasuko Kitagishi, Mayumi Kobayashi, and Satoru Matsuda, “Defective DNA repair systems and the development of breast and prostate cancer (Review),” International Journal Of Oncology, vol. 42, no. 1, pp. 29–34, 2013. View at Publisher · View at Google Scholar
  • Daquan Meng, Mingli Yuan, Xiaojuan Li, Lijun Chen, Jie Yang, Xin Zhao, Wanli Ma, and Jianbao Xin, “Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis,” Lung Cancer, 2013. View at Publisher · View at Google Scholar
  • Edith Filaire, Carmen Dupuis, Géraud Galvaing, Sylvie Aubreton, Hélène Laurent, Ruddy Richard, and Marc Filaire, “Lung cancer: What are the links with oxidative stress, physical activity and nutrition,” Lung Cancer, 2013. View at Publisher · View at Google Scholar
  • Wilson I.B. Onuigbo, “Nature’s necrosis factor when associated with erythrocytes may not only explain the surprises in lung cancer metastases but also suggest target therapy,” Medical Hypotheses, vol. 80, no. 6, pp. 698–700, 2013. View at Publisher · View at Google Scholar
  • Vanya Petrova Koleva, Asya Pencheva Dragoeva, Andreana Ivanova Andreeva, Marina Todorova Burova, Sevdalin Georgiev, and Dobromir Dimitrov Enchev, “Comparative analysis of clastogen-induced chromosome aberrations observed with light microscopy and by means of atomic force microscopy,” Mutation Research-Genetic Toxicology And Environmental Mutagenesis, vol. 753, no. 1, pp. 29–35, 2013. View at Publisher · View at Google Scholar
  • Juhua Luo, Yea-Jyh Chen, Georgia L. Narsavage, and Alan Ducatman, “Predictors of Survival in Patients With Non-Small Cell Lung Cancer,” Oncology Nursing Forum, vol. 39, no. 6, pp. 609–616, 2012. View at Publisher · View at Google Scholar
  • Juhua Luo, Yea-Jyh Chen, Georgia L. Narsavage, and Alan Ducatman, “Predictors of Survival in Patients With Non-Small Cell Lung Cancer,” Oncology Nursing Forum, vol. 39, no. 6, pp. 609–616, 2012. View at Publisher · View at Google Scholar
  • A. Mancebo, A. Casaco, B. Gonzalez, N. Ledon, J. Sorlozabal, A. Leon, D. Gomez, Y. Gonzalez, A. M. Bada, C. Gonzalez, M. E. Arteaga, H. Ramirez, and D. Fuentes, “Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity,” Vaccine, vol. 30, no. 22, pp. 3329–3338, 2012. View at Publisher · View at Google Scholar